Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Perforated marginal ulcers after laparoscopic gastric bypass

Abstract

Background

Perforated marginal ulcer (PMU) after laparoscopic Roux-en-Y gastric bypass (LRYGB) is a serious complication, but its incidence and etiology have rarely been investigated. Therefore, a retrospective review of all patients undergoing LRYGB at the authors’ center was conducted to determine the incidence of PMU and whether any causative factors were present.

Methods

A prospectively kept database of all patients at the authors’ bariatric center was retrospectively reviewed. The complete records of patients with a PMU were examined individually for accuracy and analyzed for treatment, outcome, and possible underlying causes of the marginal perforation.

Results

Between April 1999 and August 2007, 1% of the patients (35/3,430) undergoing laparoscopic gastric bypass experienced one or more perforated marginal ulcers 3 to 70 months (median, 18 months) after LRYGB. The patients with and without perforation were not significantly different in terms of mean age (37 vs 41 years), weight (286 vs 287 lb), body mass index (BMI) (46 vs 47), or female gender (89% vs 83%). Of the patients with perforations, 2 (6%) were taking steroids, 10 (29%) were receiving nonsteroidal antiinflammatory drugs (NSAIDs) at the time of the perforation, 18 (51%) were actively smoking, and 6 of the smokers also were taking NSAIDs. Eleven of the patients (31%) who perforated did not have at least one of these possible risk factors, but 4 (36%) of the 11 patients in this group had been treated after bypass for a marginal ulcer. Only 7 (20%) of the 35 patients who had laparoscopic bypass, or 7 (0.2%) in the entire group of 3,430 patients, perforated without any warning. There were no deaths, but three patients reperforated.

Conclusions

The incidence of a marginal ulcer perforating after LRYGB was significant (>1%) and appeared to be related to smoking or the use of NSAIDs or steroids. Because only 0.2% of all patients acutely perforated without some risk factor or warning, long-term ulcer prophylaxis or treatment may be necessary for only a select group of high-risk patients.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2

References

  1. 1.

    Ali MR, Fuller WD, Choi MP, Wolfe BM (2005) Bariatric surgical outcomes. Surg Clin North Am 4:835–852

  2. 2.

    Zimmerman-Belsing T, Feldt-Rasmussen U (2004) Obesity, the new worldwide epidemic threat to general health and our complete lack of effective treatment. Endocrinology 145:1501–1502

  3. 3.

    Shauer PR, Ikramuddin S (2001) Laparoscopic surgery for morbid obesity. Surg Clin North Am 81:1145–1179

  4. 4.

    Binenbaum SJ, Dressner DO, Borao FJ (2007) Laparoscopic repair of a free perforation of a marginal ulcer after Roux-en-Y bypass: a safe alternative to open exploration. J Surg Lap Soc 11:383–388

  5. 5.

    Lublin M, McCoy M, Waldrep J (2006) Perforating marginal ulcers after laparoscopic gastric bypass. Surg Endosc 20:51–54

  6. 6.

    Higa KD, Boone KB, Ho TC (2000) Complications of the laparoscopic Roux-en-Y gastric bypass: 1,040 patients: what have we learned? Obes Surg 6:509–513

  7. 7.

    Podnos Y, Jimenez J, Wilson S et al (2003) Complications after laparoscopic gastric: review of 3,464 cases. Arch Surg 138:957–961

  8. 8.

    Jordan JH, Hocking MP, Rout WR, Woodward ER (1991) Marginal ulcer following gastric bypass for morbid obesity. Am Surg 57:286–288

  9. 9.

    MacLean LD, Rhode BM, Nohr C, Katz S, McLean AP (1997) Stomal ulcer after gastric bypass. J Am Coll Surg 185:1–7

  10. 10.

    Rasmussen JJ, Fuller W, Ali MR (2007) Marginal ulceration after laparoscopic gastric bypass: an analysis of predisposing factors in 260 patients. Surg Endosc 21:1090–1094

  11. 11.

    Mason EE, Munns JR, Kealey GP (1976) Effect of gastric bypass on gatric secretion. Am J Surg 131:162–168

  12. 12.

    Printen KJ, Scott D, Mason EE (1980) Stomal ulcers after gastric bypass. Arch Surg 115:525–527

  13. 13.

    Capella JF, Capella RF (1996) Staple disruption and marginal ulceration in gastric bypass procedures for weight reduction. Obes Surg 9:22–27

  14. 14.

    Sapala A, Wood MH, Sapala MA, Flake TM Jr (1998) Marginal ulcer after gastric bypass: a prospective study of 173 patients. Obes Surg 8:505–516

  15. 15.

    Sacks BC, Qureshi FG, Eid GM, Collins JL, Barinas-Mitchell EJ, Shauer Pr, Ramanathan RC (2006) Incidence of marginal ulcers and the use of absorbable sutures in laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis 2:11–16

  16. 16.

    Ben-Meir A, Sonpal I, Patterson L, Schreiber H, Salomone M, Sharma K, Kumar A, Marshall JB (2005) Cigarette smoking, but not NSAIDs or alcohol use or comorbidities, is associated with anastomotic ulcers in Roux-en-Y gastric bypass (RYGB) patients. Surg Obes Relat Dis 1:263

  17. 17.

    Schreiber H, Ben-Mier A, Sonpal I, Patterson L, Salomone M, Marshall JB (2005) Cigarette smoking, but not the presence of H. pylori, is associated with anastomotic ulcers in Roux-en-Y gastric bypass patients. Surg Obes Relat Dis 1:257

  18. 18.

    Schirmer B, Erenoglu C, Miller A (2002) Flexible endoscopy in the management of patients undergoing Roux-en-Y gastric bypass. Obes Surg 12:634–638

Download references

Author information

Correspondence to Edward L. Felix.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Felix, E.L., Kettelle, J., Mobley, E. et al. Perforated marginal ulcers after laparoscopic gastric bypass. Surg Endosc 22, 2128–2132 (2008). https://doi.org/10.1007/s00464-008-9996-7

Download citation

Keywords

  • Bariatric
  • Complications
  • Perforation
  • Ulcers